Skip to main content
Clinical Trials/NCT01414322
NCT01414322UnknownNot Applicable

Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients

KarmelSonix Ltd.1 site in 1 country45 target enrollmentStarted: September 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
45
Locations
1
Primary Endpoint
increase or decrease of WheezeRate (the proportion of wheezing in the respiratory cycle)

Study Overview

Brief Summary

Phenotype characterization of shortness of breath of pediatric emergency room patients by objective wheeze and cough monitoring improves diagnostic and severity assessment accuracy and correlates with overall patient outcomes.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 15 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patient is admitted to the ER with shortness of breath
  • patient management is according to standardized protocols used in Hadassah Mt. Scopus pediatric emergency department including:
  • asthma management protocol
  • bronchiolitis management protocol
  • ages 0 - 15
  • patient's parent/guardian is able to comprehend and give informed consent for participating in the study

Exclusion Criteria

  • patient has received any dose of inhaled bronchodilators in the hour prior to enrollment
  • patient has received oral or IV steroids in a time window of 30 minutes to 5 hours prior to enrollment
  • ventilated patients, while ventilated
  • chest skin lesions
  • cystic fibrosis
  • hemodynamic instability
  • patient's parent/guardian objects to the study protocol
  • concurrent participation in any other clinical study
  • physician objection

Outcomes

Primary Outcomes

increase or decrease of WheezeRate (the proportion of wheezing in the respiratory cycle)

Time Frame: Duration (from beginning to end) of emergency department stay. On average, 3 hours.

Characterize the dynamic pattern of wheeze rate (increase or decrease by 50% or unchanged) within 30 minutes of onset of therapy, and to correlate pattern to clinical diagnoses, severity assessment (accessory muscle use, oxygen saturation, inspiratory/expiratory ratio, severity of wheezing), and outcome (admission versus discharge).

Secondary Outcomes

  • cough count (increase or decrease by more then 1 cough event or unchanged) in response to treatment(Duration (from beginning to end) of emergency department stay. On average, 3 hours.)

Investigators

Sponsor
KarmelSonix Ltd.
Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Documentation of Continuous Wheeze and... | Clinical Trial